• Boston and San Francisco Hospitals Will Take Part in Phase 3 Trial of NurOwn for ALS
  • Want to Exercise? Webinar Gives a Resounding Thumbs-Up
  • Researchers Create Musical Instrument to Be Played Using Only the Mind
  • Neuraltus Completes Enrollment in Second Phase 2 Trial of NP001 for Treating ALS Inflammation
  • Occupation May Affect ALS Mortality Rate
  • Green Relief Reminds Florida Residents They Must No Longer Wait for Medical Marijuana
  • Spine Inflammation Might Explain Why Motor Neurons Die in ALS, Researchers Suggest
  • Mutant TDP-43 Alone Not Enough to Cause ALS Neurodegeneration, Insect Study Suggests
  • Traumatic Brain Injury May Increase Risk of Dementia, but Not ALS, Study Reports
  • Give a Scooter a Try: It Can Be Wheelie Fun
  • Ipsen and Saol Partner to Promote Dysport in US for Spasticity, a Common Symptom in ALS
  • Worldwide Clinical Trials Picked to Manage Phase 3 Study of NurOwn for ALS